Please enable JavaScript to continue using this application.

Compare $DNTH vs $PTCT | Chartloom

Compare

$DNTH vs $PTCT

Dianthus Therapeutics Inc · PTC Therapeutics Inc

DNTH

Dianthus Therapeutics Inc

PTCT

PTC Therapeutics Inc

Compare $DNTH vs $PTCT

Comparing Dianthus Therapeutics Inc and PTC Therapeutics Inc

DNTHDianthus Therapeutics Inc

PTCTPTC Therapeutics Inc

DNTHDianthus Therapeutics Inc

Market cap

$4.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3,009.80x

Rev growth (TTM)

-60.8%

YTD performance

107.6%

52W performance

137.0%

FCF yield

-3.5%

PTCTPTC Therapeutics Inc

Market cap

$5.37B

P/E (TTM)

—

Forward P/E (NTM)

43.00x

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-36.7%

YTD performance

-15.7%

52W performance

0.3%

FCF yield

-0.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNTH

PTCT

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

PTCT

PTC Therapeutics Inc

Market Cap

DNTH$4.50B

PTCT$5.37B

Enterprise Value

DNTH$4.39B

PTCT$7.24B

Price

DNTH$82.37

PTCT$64.70

P/E Ratio

DNTHN/A

PTCTN/A

P/S Ratio

DNTH2,365.11x

PTCT5.32x

EV/Sales

DNTH2,307.05x

PTCT7.17x

EV/EBITDA

DNTH0.00x

PTCT35.21x

P/B Ratio

DNTH4.21x

PTCT3,530.95x

P/FCF Ratio

DNTHN/A

PTCTN/A

EV/FCF

DNTH-28.21x

PTCT-182.20x

PEG Ratio

DNTHN/A

PTCTN/A

Forward P/E (NTM)

DNTHN/A

PTCT43.00x

Forward P/S (NTM)

DNTH3,009.80x

PTCT4.18x

Revenue (TTM)

DNTH$2M

PTCT$1.01B

Revenue Growth (YoY)

DNTH-60.8%

PTCT-36.7%

Forward Rev Growth

DNTH-5.4%

PTCT11.6%

Gross Margin (TTM)

DNTH0.0%

PTCT93.0%

Operating Margin (TTM)

DNTH0.0%

PTCT12.4%

EBITDA Margin (TTM)

DNTH-11434.9%

PTCT17.1%

Net Margin (TTM)

DNTH-10097.0%

PTCT-3.8%

FCF Margin (TTM)

DNTH-8178.0%

PTCT-3.9%

Net Income (TTM)

DNTH$-192M

PTCT$-38M

FCF (TTM)

DNTH$-156M

PTCT$-40M

EPS (TTM)

DNTH-$3.43

PTCT-$0.42

ROE (TTM)

DNTH-2253.0%

PTCT-35191.0%

ROA (TTM)

DNTH-2155.0%

PTCT-132.0%

ROIC (TTM)

DNTH-2253.0%

PTCT-3977.0%

Cash

DNTH$111M

PTCT$1.05B

Debt

DNTH$0

PTCT$2.92B

Net Cash/Debt

DNTH$111M

PTCT$-1.87B

Current Ratio (TTM)

DNTH26.10x

PTCT3.39x

Quick Ratio (TTM)

DNTH25.80x

PTCT3.20x

Debt/Equity (TTM)

DNTH0.00x

PTCT848.93x

Debt/Assets (TTM)

DNTH0.0%

PTCT0.0%

Interest Coverage (TTM)

DNTHN/A

PTCTN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

PTCT0.00x

Beta

DNTH1.99

PTCT0.50

52W Performance

DNTH137.0%

PTCT0.3%

YTD Performance

DNTH107.6%

PTCT-15.7%

% from 52W High

DNTH-30.1%

PTCT-28.8%

% from 52W Low

DNTH155.6%

PTCT5.7%

Asset Turnover (TTM)

DNTH0.00x

PTCT0.35x

FCF Yield (TTM)

DNTH-3.5%

PTCT-0.7%

Earnings Yield (TTM)

DNTH-4.3%

PTCT-0.7%

Dividend Yield (TTM)

DNTHN/A

PTCTN/A

Rule of 40

DNTH-8,238.8

PTCT-40.7

EV/GP/RG

DNTHN/A

PTCT0.24

Ticker research

View DNTH research View PTCT research

Metric	DNTH Dianthus Therapeutics Inc	PTCT PTC Therapeutics Inc
Market & Valuation
Market Cap	$4.50B	$5.37B
Enterprise Value	$4.39B	$7.24B
Price	$82.37	$64.70
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	5.32x
EV/Sales	2,307.05x	7.17x
EV/EBITDA	0.00x	35.21x
P/B Ratio	4.21x	3,530.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-182.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	43.00x
Forward P/S (NTM)	3,009.80x	4.18x
Revenue & Growth
Revenue (TTM)	$2M	$1.01B
Revenue Growth (YoY)	-60.8%	-36.7%
Forward Rev Growth	-5.4%	11.6%
Profitability
Gross Margin (TTM)	0.0%	93.0%
Operating Margin (TTM)	0.0%	12.4%
EBITDA Margin (TTM)	-11434.9%	17.1%
Net Margin (TTM)	-10097.0%	-3.8%
FCF Margin (TTM)	-8178.0%	-3.9%
Net Income (TTM)	$-192M	$-38M
FCF (TTM)	$-156M	$-40M
EPS (TTM)	-$3.43	-$0.42
ROE (TTM)	-2253.0%	-35191.0%
ROA (TTM)	-2155.0%	-132.0%
ROIC (TTM)	-2253.0%	-3977.0%
Financial Health
Cash	$111M	$1.05B
Debt	$0	$2.92B
Net Cash/Debt	$111M	$-1.87B
Current Ratio (TTM)	26.10x	3.39x
Quick Ratio (TTM)	25.80x	3.20x
Debt/Equity (TTM)	0.00x	848.93x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	0.50
52W Performance	137.0%	0.3%
YTD Performance	107.6%	-15.7%
% from 52W High	-30.1%	-28.8%
% from 52W Low	155.6%	5.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.35x
FCF Yield (TTM)	-3.5%	-0.7%
Earnings Yield (TTM)	-4.3%	-0.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	-40.7
EV/GP/RG	N/A	0.24
Ticker research	View DNTH research	View PTCT research

Valuation

P/S Ratio

PTCT

5.32x

DNTH

2,365.11x

EV/FCF

PTCT

-182.20x

DNTH

-28.21x

Growth & revenue

Revenue Growth TTM

PTCT

-36.7%

DNTH

-60.8%

Forward Revenue Growth

PTCT

11.6%

DNTH

-5.4%

Profitability & performance

Gross Margin

PTCT

93.0%

DNTH

0.0%

ROE

DNTH

-2253.0%

PTCT

-35191.0%

FCF Yield %

PTCT

-0.7%

DNTH

-3.5%

52-Week Performance

DNTH

137.0%

PTCT

0.3%

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

PTCT

PTC Therapeutics Inc

Market Cap

DNTH$4.50B

PTCT$5.37B

Enterprise Value

DNTH$4.39B

PTCT$7.24B

Price

DNTH$82.37

PTCT$64.70

P/E Ratio

DNTHN/A

PTCTN/A

P/S Ratio

DNTH2,365.11x

PTCT5.32x

EV/Sales

DNTH2,307.05x

PTCT7.17x

EV/EBITDA

DNTH0.00x

PTCT35.21x

P/B Ratio

DNTH4.21x

PTCT3,530.95x

P/FCF Ratio

DNTHN/A

PTCTN/A

EV/FCF

DNTH-28.21x

PTCT-182.20x

PEG Ratio

DNTHN/A

PTCTN/A

Forward P/E (NTM)

DNTHN/A

PTCT43.00x

Forward P/S (NTM)

DNTH3,009.80x

PTCT4.18x

Revenue (TTM)

DNTH$2M

PTCT$1.01B

Revenue Growth (YoY)

DNTH-60.8%

PTCT-36.7%

Forward Rev Growth

DNTH-5.4%

PTCT11.6%

Gross Margin (TTM)

DNTH0.0%

PTCT93.0%

Operating Margin (TTM)

DNTH0.0%

PTCT12.4%

EBITDA Margin (TTM)

DNTH-11434.9%

PTCT17.1%

Net Margin (TTM)

DNTH-10097.0%

PTCT-3.8%

FCF Margin (TTM)

DNTH-8178.0%

PTCT-3.9%

Net Income (TTM)

DNTH$-192M

PTCT$-38M

FCF (TTM)

DNTH$-156M

PTCT$-40M

EPS (TTM)

DNTH-$3.43

PTCT-$0.42

ROE (TTM)

DNTH-2253.0%

PTCT-35191.0%

ROA (TTM)

DNTH-2155.0%

PTCT-132.0%

ROIC (TTM)

DNTH-2253.0%

PTCT-3977.0%

Cash

DNTH$111M

PTCT$1.05B

Debt

DNTH$0

PTCT$2.92B

Net Cash/Debt

DNTH$111M

PTCT$-1.87B

Current Ratio (TTM)

DNTH26.10x

PTCT3.39x

Quick Ratio (TTM)

DNTH25.80x

PTCT3.20x

Debt/Equity (TTM)

DNTH0.00x

PTCT848.93x

Debt/Assets (TTM)

DNTH0.0%

PTCT0.0%

Interest Coverage (TTM)

DNTHN/A

PTCTN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

PTCT0.00x

Beta

DNTH1.99

PTCT0.50

52W Performance

DNTH137.0%

PTCT0.3%

YTD Performance

DNTH107.6%

PTCT-15.7%

% from 52W High

DNTH-30.1%

PTCT-28.8%

% from 52W Low

DNTH155.6%

PTCT5.7%

Asset Turnover (TTM)

DNTH0.00x

PTCT0.35x

FCF Yield (TTM)

DNTH-3.5%

PTCT-0.7%

Earnings Yield (TTM)

DNTH-4.3%

PTCT-0.7%

Dividend Yield (TTM)

DNTHN/A

PTCTN/A

Rule of 40

DNTH-8,238.8

PTCT-40.7

EV/GP/RG

DNTHN/A

PTCT0.24

Ticker research

View DNTH research View PTCT research

Metric	DNTH Dianthus Therapeutics Inc	PTCT PTC Therapeutics Inc
Market & Valuation
Market Cap	$4.50B	$5.37B
Enterprise Value	$4.39B	$7.24B
Price	$82.37	$64.70
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	5.32x
EV/Sales	2,307.05x	7.17x
EV/EBITDA	0.00x	35.21x
P/B Ratio	4.21x	3,530.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-182.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	43.00x
Forward P/S (NTM)	3,009.80x	4.18x
Revenue & Growth
Revenue (TTM)	$2M	$1.01B
Revenue Growth (YoY)	-60.8%	-36.7%
Forward Rev Growth	-5.4%	11.6%
Profitability
Gross Margin (TTM)	0.0%	93.0%
Operating Margin (TTM)	0.0%	12.4%
EBITDA Margin (TTM)	-11434.9%	17.1%
Net Margin (TTM)	-10097.0%	-3.8%
FCF Margin (TTM)	-8178.0%	-3.9%
Net Income (TTM)	$-192M	$-38M
FCF (TTM)	$-156M	$-40M
EPS (TTM)	-$3.43	-$0.42
ROE (TTM)	-2253.0%	-35191.0%
ROA (TTM)	-2155.0%	-132.0%
ROIC (TTM)	-2253.0%	-3977.0%
Financial Health
Cash	$111M	$1.05B
Debt	$0	$2.92B
Net Cash/Debt	$111M	$-1.87B
Current Ratio (TTM)	26.10x	3.39x
Quick Ratio (TTM)	25.80x	3.20x
Debt/Equity (TTM)	0.00x	848.93x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	0.50
52W Performance	137.0%	0.3%
YTD Performance	107.6%	-15.7%
% from 52W High	-30.1%	-28.8%
% from 52W Low	155.6%	5.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.35x
FCF Yield (TTM)	-3.5%	-0.7%
Earnings Yield (TTM)	-4.3%	-0.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	-40.7
EV/GP/RG	N/A	0.24
Ticker research	View DNTH research	View PTCT research